{"id":44315,"date":"2022-05-25T10:01:31","date_gmt":"2022-05-25T08:01:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/"},"modified":"2022-05-25T10:01:31","modified_gmt":"2022-05-25T08:01:31","slug":"nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/","title":{"rendered":"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment"},"content":{"rendered":"
\n

\nNuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management.<\/i><\/b>\n<\/p>\n

<\/a>
<\/a><\/p>\n

LONDON–(BUSINESS WIRE)–#asthma<\/a>–NuvoAir\u2019s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung function variability, and the AOS pMDI sensor<\/a> to track inhaler usage and technique. Respiratory patients follow their data in the NuvoAir Home app while healthcare teams access assessment reports, gain longitudinal insights, and efficiently address care needs.\n<\/p>\n

\nSince 2017, NuvoAir has worked with over 40 NHS trusts, enabling NHS services to manage nearly 5,000 respiratory patients. Over 20 clinical studies<\/a> have demonstrated NuvoAir\u2019s ability to produce high-quality data, obtain high patient satisfaction, and reduce both scheduled and emergency in-hospital care.\n<\/p>\n

\nThe current state of asthma<\/b>\n<\/p>\n

\nMay is Asthma Awareness Month and efforts are underway to educate the public on the status of asthma in the UK, where asthma deaths are amongst the worst in Europe.\n<\/p>\n

\nUncontrolled asthma results in over 75,000 emergency admissions and 1,000 preventable deaths each year. A recent publication in The Lancet reports, \u201cThe UK has the highest asthma mortality rates of high-income countries in younger age groups (aged 5\u201334 years), the highest asthma admission rates in Europe, and the highest rates of asthma symptoms globally in children. Despite major advancements in asthma management and therapies, and the introduction of care pathways, hospital admission rates continue to be higher than expected, and tragically preventable deaths from asthma still occur in young people.\u201d\n<\/p>\n

\nOverburdened clinical services mean people with suspected lung disease have to wait too long to be diagnosed. Early in the pandemic, one in three people with lung disease waited longer than six months for a diagnosis. Today, wait times are frequently much longer, delaying needed treatment and triggering emergency hospital care.\n<\/p>\n

\nThe value of NuvoAir\u2019s Asthma Assessment Service<\/b>\n<\/p>\n

\nDr. Louise Fleming, honorary paediatric consultant from The Royal Brompton & Harefield Hospitals shares, \u201cHome spirometry monitoring has been an invaluable tool for children with asthma during the COVID lockdowns. Such has been the success of this initiative that it is now embedded within our service. Looking ahead, there is the potential to improve the diagnosis and monitoring of asthma.\u201d\n<\/p>\n

\n“There is good evidence that smart inhaler devices can help people with asthma remember to take their medication regularly, leading to better asthma control. The NuvoAir Asthma Service will potentially improve access to this aspect of asthma care for people with asthma, leading to fewer asthma symptoms and attacks,\u201d says Professor Peter Bradding from University Hospitals of Leicester NHS Trust.\n<\/p>\n

\n\u201cInnovative solutions like NuvoAir offer real potential to transform the way we diagnose and support our patients with asthma and COPD,\u201d notes Dr. Laura Wiffen, Respiratory Research Fellow from Portsmouth Hospitals University NHS Trust.\n<\/p>\n

\nNuvoAir Founder and CEO, Lorenzo Consoli shares, \u201cWe are excited to partner with the NHS and forward-looking clinicians to redesign new care pathways for people with asthma. By blending high-touch with high-tech, we are able to help patients get on the right treatment at the right time to prevent asthma exacerbations.\u201d\n<\/p>\n

\nAbout NuvoAir<\/b>\n<\/p>\n

\n\u200b\u200bWith offices in Boston, US, London, UK and Stockholm, Sweden, NuvoAir<\/a> is a leading virtual-first care organisation for complex disease management and decentralised clinical trials. NuvoAir delivers a more continuous, relationship-based experience to individuals with complex conditions with an initial focus on respiratory diseases. NuvoAir blends connected devices with high-touch clinical services to enable patients and their providers to proactively manage chronic conditions, resulting in better outcomes and lower costs.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMeera Montan
\n
Community Engagement Director
\n
meera.montan@nuvoair.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management. LONDON–(BUSINESS WIRE)–#asthma–NuvoAir\u2019s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung function … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44315","6":"format-standard","7":"category-industry"},"yoast_head":"\nNuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management. LONDON–(BUSINESS WIRE)–#asthma–NuvoAir\u2019s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung function ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-25T08:01:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220523005860\/en\/1464266\/21\/NuvoAir_Asthma_Service.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment\",\"datePublished\":\"2022-05-25T08:01:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/\"},\"wordCount\":615,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005860\\\/en\\\/1464266\\\/21\\\/NuvoAir_Asthma_Service.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/\",\"name\":\"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005860\\\/en\\\/1464266\\\/21\\\/NuvoAir_Asthma_Service.jpg\",\"datePublished\":\"2022-05-25T08:01:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005860\\\/en\\\/1464266\\\/21\\\/NuvoAir_Asthma_Service.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005860\\\/en\\\/1464266\\\/21\\\/NuvoAir_Asthma_Service.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/","og_locale":"en_US","og_type":"article","og_title":"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment - Pharma Trend","og_description":"NuvoAir is collaborating with 17 NHS trusts to launch a virtual Asthma Assessment Service designed to increase clinical capacity, reduce time to diagnosis, and provide ongoing remote patient monitoring and management. LONDON–(BUSINESS WIRE)–#asthma–NuvoAir\u2019s Asthma Assessment Service uses respiratory physiologists and connected, award-winning home monitoring technology, such as the Air Next spirometer to assess lung function ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-25T08:01:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220523005860\/en\/1464266\/21\/NuvoAir_Asthma_Service.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment","datePublished":"2022-05-25T08:01:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/"},"wordCount":615,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005860\/en\/1464266\/21\/NuvoAir_Asthma_Service.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/","url":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/","name":"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005860\/en\/1464266\/21\/NuvoAir_Asthma_Service.jpg","datePublished":"2022-05-25T08:01:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220523005860\/en\/1464266\/21\/NuvoAir_Asthma_Service.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220523005860\/en\/1464266\/21\/NuvoAir_Asthma_Service.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nuvoair-launches-remote-asthma-service-to-support-nhs-with-faster-diagnosis-and-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NuvoAir Launches Remote Asthma Service to Support NHS with Faster Diagnosis and Treatment"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44315"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44315\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44315"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44315"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}